cervical myelopathy
Conditions
Interventions
Control group:Placebo (one bag at a time, twice a day, eight weeks) and mecobalamine pill (one pill at a time, three times a day, eight weeks)
Sponsors
Wangjing Hospital, China Academy of Chinese Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. all the subjects will be accordance with the diagnosis of cervical myelopathy; 2. aged from 40 to 70 old years; 3. sign the informed consent and refuse surgery.
Exclusion criteria
Exclusion criteria: 1. confirmed tumor in cervical spine, tuberculosis, or osteomyelitis; 2. spinal injury, fracture, or dislocation; 3. severe heart, pulmonary, brain, liver, kidney, or hematologic system disorders; 4. serious skin damage, infection or skin diseases; 5. have received cervical surgery treatment and cervical congenital malformation; 6. clear surgical indications: Frankel classification of spinal cord injury exceed D class, urinary and fecal incontinence, spinal cord compression ratio is below 0.4, no effective after at least three-month conservative treatment, and the symptoms become progressively aggravated.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Japanese Orthopaedic Association score;Neck Disability Index; | — |
Countries
China
Contacts
Public ContactLiguo Zhu
Wangjing Hospital, China Academy of Chinese Medical Sciences
Outcome results
None listed